New York Cannabis Tops $4 Billion in Retail Sales

NEW YORK – Less than four years after the state welcomed its first licensed adult-use customer, New York’s regulated market has crossed a major cumulative sales threshold, placing it among the top three recreational Cannabis markets in the country.

Gov. Kathy Hochul announced that New York’s legal Cannabis market has surpassed $4.1 billion in cumulative retail sales, with more than $1.4 billion generated during the first nine months of 2026. Third quarter sales reached $512.6 million – the strongest single quarter since the launch of adult-use sales in late 2022.

The state has now issued 2,351 Cannabis licenses and has 1,039 licensed adult-use retailers.
There are 744 dispensaries currently open and operating.

Officials reported that 56% of adult-use licenses have gone to Social and Economic Equity applicants. The Community Grants Reinvestment Fund has committed $35 million to communities disproportionately affected by past drug enforcement, directing that revenue toward youth development, workforce programs, housing, and harm reduction services.

“Reaching $4.1 billion in cannabis sales is an extraordinary milestone for New York,” said John Kagia, executive director of the state’s Office of Cannabis Management (OCM). “The real story is the people and businesses behind that number – the entrepreneurs who have built New York’s legal cannabis supply chain from the ground up, and the workers who show up every day to keep the industry’s engine running.”

New York’s rise to third nationally in adult-use retail sales has run parallel with a sustained crackdown on the unlicensed competition that slowed the market’s early years. The state has conducted 2,257 storefront inspections, padlocked 738 illegal Cannabis shops, and seized illegal products valued at more than $276 million. In 2026 alone, 191 storefronts were closed and $125 million in illicit Cannabis removed from circulation.

OCM projections suggest New York could cross the $4.5 billion mark by 2028 and, if current trends hold, become a larger Cannabis market than California by 2030. Those figures carry standard caveats. They assume continued enforcement effectiveness, a stable regulatory environment, and a licensed price point competitive enough to keep consumers choosing legal stores over unlicensed alternatives.

Cumulative retail sales and the financial health of individual operators are two distinct things. Licensed cultivators and retailers in New York carry compliance costs, state and local tax obligations, and wholesale pricing pressures that unlicensed sellers simply do not. In mature markets like California and Michigan, strong top-line growth has consistently coexisted with acute financial strain at the individual business level, particularly for operators without deep capital reserves.

The $4.1 billion figure is a real measure of how far New York’s legal Cannabis market has traveled since a halting start in 2023. The more instructive test going forward, from an industry standpoint, will be license renewal rates among equity-focused operators and how much of total statewide consumer demand licensed dispensaries are actually capturing relative to the illicit trade. Top-line growth confirms the market exists. Those two indicators will tell you if it’s built to last.